Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 9, 2010 - Issue 4
Submit an article Journal homepage
789
Views
194
CrossRef citations to date
0
Altmetric
Reviews

Statin use and cancer risk: a comprehensive review

Denise M Boudreau Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA +1 206 287 2067; +1 206 287 2871; [email protected]; University of Washington School of Pharmacy, Seattle, WA, USA
, RPh PhD,
Onchee Yu Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
, MS &
Jeanene Johnson Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
Pages 603-621 | Published online: 09 Apr 2010

Citations (194)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

Victor I. Seledtsov & Alexei von Delwig. (2021) Clinically feasible and prospective immunotherapeutic interventions in multidirectional comprehensive treatment of cancer. Expert Opinion on Biological Therapy 21:3, pages 323-342.
Read now
Tao Zhang, Li Zhao, Taotao Zhang, Wangyu Wu, Jie Liu, Xian Wang, Yang Wan, Hao Geng, Xin Sun, Weiwei Qian & Dexin Yu. (2020) Curcumin Negatively Regulates Cigarette Smoke-Induced Renal Cell Carcinoma Epithelial–Mesenchymal Transition Through the ERK5/AP-1 Pathway. OncoTargets and Therapy 13, pages 9689-9700.
Read now
Mayu Hosio, Elina Urpilainen, Ari Hautakoski, Mikko Marttila, Martti Arffman, Reijo Sund, Anne Ahtikoski, Ulla Puistola, Peeter Karihtala, Arja Jukkola & Esa Läärä. (2020) Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study. Acta Oncologica 59:9, pages 1110-1117.
Read now
Anthony Alioui, Olivier Celhay, Silvère Baron & Jean-Marc A Lobaccaro. (2014) Lipids and prostate cancer adenocarcinoma. Clinical Lipidology 9:6, pages 643-655.
Read now
Jennifer W Wu, Denise M Boudreau, Yikyung Park, Naoko I Simonds & Andrew N Freedman. (2014) Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature. Expert Opinion on Drug Safety 13:8, pages 1071-1099.
Read now
Te-Fu Chan, Chen-Hsuan Wu, Chih-Lung Lin & Chun-Yuh Yang. (2014) Statin use and the risk of breast cancer: a population-based case–control study. Expert Opinion on Drug Safety 13:3, pages 287-293.
Read now
Ishak Mansi & Eric Mortensen. (2013) The controversy of a wider statin utilization: why?. Expert Opinion on Drug Safety 12:3, pages 327-337.
Read now
Wales WN Chan, Gordon TC Wong & Michael G Irwin. (2013) Perioperative statin therapy. Expert Opinion on Pharmacotherapy 14:7, pages 831-842.
Read now
Henry WC Leung, Agnes LF Chan, Daniel Lo, John Hang Leung & Hsiao-Ling Chen. (2013) Common cancer risk and statins: a population-based case–control study in a Chinese population. Expert Opinion on Drug Safety 12:1, pages 19-27.
Read now
Binh An P Phan, Thomas D Dayspring & Peter P Toth. (2012) Ezetimibe therapy: mechanism of action and clinical update. Vascular Health and Risk Management 8, pages 415-427.
Read now
Anna Fenton & Nick Panay. (2010) Statins in women for primary prevention – is there evidence to back up their use??. Climacteric 13:5, pages 403-404.
Read now

Articles from other publishers (183)

Caroline R. Bartman, Brandon Faubert, Joshua D. Rabinowitz & Ralph J. DeBerardinis. (2023) Metabolic pathway analysis using stable isotopes in patients with cancer. Nature Reviews Cancer 23:12, pages 863-878.
Crossref
Raquel Fernandes, Cátia Costa, Rúben Fernandes & Ana Novo Barros. (2023) Inflammation in Prostate Cancer: Exploring the Promising Role of Phenolic Compounds as an Innovative Therapeutic Approach. Biomedicines 11:12, pages 3140.
Crossref
Wei Xie, Mingjing Peng, Ying Liu, Bocheng Zhang, Liang Yi & Ying Long. (2023) Simvastatin induces pyroptosis via ROS/caspase-1/GSDMD pathway in colon cancer. Cell Communication and Signaling 21:1.
Crossref
Dongying Wang, Senjie Dai, Dandi Lou, Tianyue Wang, Shihui Wang & Zhen Zheng. (2023) Association between statins exposure and risk of skin cancer: an updated meta‐analysis. International Journal of Dermatology.
Crossref
Amjad Z. Alrosan, Ghaith B. Heilat, Zeinab Y. Al Subeh, Khaled Alrosan, Alaa F. Alrousan, Amro K. Abu-Safieh & Nuwar S. Alabdallat. (2023) The effects of statin therapy on brain tumors, particularly glioma: a review. Anti-Cancer Drugs.
Crossref
Chengyu Liu, Hong Chen, Bicheng Hu, Jiajian Shi, Yuchen Chen & Kun Huang. (2023) New insights into the therapeutic potentials of statins in cancer. Frontiers in Pharmacology 14.
Crossref
Jean-Matthieu L’Orphelin, Charles Dollalille, Julia Akroun, Joachim Alexandre & Anne Dompmartin. (2023) Cardiovascular Immunotoxicity Associated with Immune Checkpoint Inhibitors in Metastatic Melanoma. Cancers 15:7, pages 2170.
Crossref
Seema Kuldeep, Sneha Soni, Anubhav Srivastava, Anjali Mishra, Lokendra Kumar Sharma & Chandi C. Mandal. (2023) Dysregulated cholesterol regulatory genes as a diagnostic biomarker for cancer. The Journal of Gene Medicine 25:4.
Crossref
Marleen E. Jansen, Tessel Rigter, Thom M. C. Fleur, Patrick C. Souverein, W. M. Monique Verschuren, Susanne J. Vijverberg, Jesse J. Swen, Wendy Rodenburg & Martina C. Cornel. (2023) Predictive Value of SLCO1B1 c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users. Genes 14:2, pages 456.
Crossref
Steffen Spoerl, Michael Gerken, René Fischer, Silvia Spoerl, Christian Kirschneck, Stefanie Wolf, Juergen Taxis, Nils Ludwig, Niklas Biermann, Torsten E. Reichert & Gerrit Spanier. (2023) Statin Use Ameliorates Survival in Oral Squamous Cell Carcinoma—Data from a Population-Based Cohort Study Applying Propensity Score Matching. Biomedicines 11:2, pages 369.
Crossref
Jeffrey Shi Kai Chan, Danish Iltaf Satti, Yan Hiu Athena Lee, Khalid Bin Waleed, Pias Tang, Gauranga Mahalwar, Abdul Mannan Khan Minhas, Leonardo Roever, Giuseppe Biondi-Zoccai, Fung Ping Leung, Wing Tak Wong, Tong Liu, Jiandong Zhou & Gary Tse. (2023) Association Between Visit-to-Visit Lipid Variability and Incident Cancer: A Population-based Cohort Study. Current Problems in Cardiology 48:1, pages 101421.
Crossref
Noor Mazin Abdulkareem, Raksha Bhat, Reid T. Powell, Soumya Chikermane, Soham Yande, Lisa Trinh, Hala Y. Abdelnasser, Mantasha Tabassum, Alexis Ruiz, Mary Sobieski, Nghi D. Nguyen, Jun Hyoung Park, Camille A. Johnson, Benny A. Kaipparettu, Richard A. Bond, Michael Johnson, Clifford Stephan & Meghana V. Trivedi. (2022) Screening of GPCR drugs for repurposing in breast cancer. Frontiers in Pharmacology 13.
Crossref
Fabio S. Frech, Kanthi Bommareddy, Loren Hernandez, Isabella Dreyfuss, Rebecca Urbonas & Keyvan Nouri. (2022) Cutaneous melanoma: An update on pathogenesis, prevention, and treatment. Dermatological Reviews 3:6, pages 384-399.
Crossref
Chao-Yi Chen, Yi-Feng Yang, Paul C. Wang, Liang Shan, Stephen Lin, Po-Jung Chen, Yi-Jung Chen, Han-Sun Chiang, Jaw-Town Lin, Chi-Feng Hung & Yao-Jen Liang. (2022) Simvastatin Attenuated Tumor Growth in Different Pancreatic Tumor Animal Models. Pharmaceuticals 15:11, pages 1408.
Crossref
Anna K. Gergen, Helen J. Madsen, Anqi Li, Linling Cheng, Xianzhong Meng, David A. Fullerton, Akshay Pratap & Michael J. Weyant. (2022) Simvastatin Inhibits Histologic Changes Associated with Gastroduodenal Reflux in a Murine Model. Digestive Diseases and Sciences 67:10, pages 4732-4741.
Crossref
Dong-sook Kim, Hyun Jung Kim & Hyeong Sik Ahn. (2022) Statins and the risk of gastric, colorectal, and esophageal cancer incidence and mortality: a cohort study based on data from the Korean national health insurance claims database. Journal of Cancer Research and Clinical Oncology 148:10, pages 2855-2865.
Crossref
Yan Ou, Ruoxiang Wang, Gina Chia‐Yi Chu, Omer Hany Miligy Elmadbouh, Adrian Lim, Leland Wei‐Kuo Chung, Mouad Edderkaoui, Yi Zhang & Stephen Jacob Pandol. (2022) Novel DZ‐SIM Conjugate Targets Cancer Mitochondria and Prolongs Survival in Pancreatic Ductal Adenocarcinoma. Advanced Therapeutics 5:10.
Crossref
Jin Gu Cho, Sung-wook Kim, Aram Lee, Ha-neul Jeong, Eunsik Yun, Jihea Choi, Su Jin Jeong, Woochul Chang, Sumin Oh, Kyung Hyun Yoo, Jung Bok Lee, Sukjoon Yoon, Myeong-Sok Lee, Jong Hoon Park, Min Hyung Jung, So-Woon Kim, Ki Hyung Kim, Dong Soo Suh, Kyung Un Choi, Jungmin Choi, Jongmin Kim & Byung Su Kwon. (2022) MicroRNA-dependent inhibition of WEE1 controls cancer stem-like characteristics and malignant behavior in ovarian cancer. Molecular Therapy - Nucleic Acids 29, pages 803-822.
Crossref
Jyoti Sharma, Khadija Sana Hafeez & Sushmita Paul. (2022) Prioritizing Variants using Rough-set based Relevance Algorithm for GWAS. Prioritizing Variants using Rough-set based Relevance Algorithm for GWAS.
Shrouq Khazaaleh, Muhammad Talal Sarmini, Mohammad Alomari, Laith Al Momani, Bara El Kurdi, Mohammad Asfari, Zain Almomani & Carlos Romero-Marrero. (2022) Statin Use Reduces the Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis and Systematic Review. Cureus.
Crossref
Hyung Woo Kim, Young Su Joo, Shin Chan Kang, Hee Byung Koh, Seung Hyeok Han, Tae-Hyun Yoo, Shin-Wook Kang & Jung Tak Park. (2022) Association of statin treatment with hepatocellular carcinoma risk in end-stage kidney disease patients with chronic viral hepatitis. Scientific Reports 12:1.
Crossref
Antti I. Peltomaa, Kirsi Talala, Kimmo Taari, Teuvo L. J. Tammela, Anssi Auvinen & Teemu J. Murtola. (2022) Inverse Association between Statin Use and Cancer Mortality Relates to Cholesterol Level. Cancers 14:12, pages 2920.
Crossref
Fei Chen, Peggy Wan, Lynne R. Wilkens, Loïc Le Marchand & Christopher A. Haiman. (2022) The Association of Prediagnostic Statin Use with Aggressive Prostate Cancer from the Multiethnic Cohort Study. Cancer Epidemiology, Biomarkers & Prevention 31:5, pages 999-1005.
Crossref
Seung In Seo, Tae Jun Kim, Chan Hyuk Park, Chang Seok Bang, Kyung Joo Lee, Jinseob Kim, Hyon Hee Kim & Woon Geon Shin. (2022) Incidence and Survival Outcomes of Colorectal Cancer in Long-Term Metformin Users with Diabetes: A Population-Based Cohort Study Using a Common Data Model. Journal of Personalized Medicine 12:4, pages 584.
Crossref
Dong‐Sook Kim, Hyeong Sik Ahn & Hyun Jung Kim. (2021) Statin use and incidence and mortality of breast and gynecology cancer: A cohort study using the National Health Insurance claims database. International Journal of Cancer 150:7, pages 1156-1165.
Crossref
Borui Li, Yi Qin, Xianjun Yu, Xiaowu Xu & Wenyan Yu. (2021) Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis. Cell Proliferation 55:1.
Crossref
Liyuan Yin, Yi Zhang, Lijuan Yin, Yan Ou, Michael S. Lewis, Ruoxiang Wang, Haiyen E. Zhau, Qinghua Zhou & Leland W.K. Chung. (2021) Novel Mitochondria-Based Targeting Restores Responsiveness in Therapeutically Resistant Human Lung Cancer Cells. Molecular Cancer Therapeutics 20:12, pages 2527-2538.
Crossref
Beniamin Oskar Grabarek, Dariusz Boroń, Emilia Morawiec, Piotr Michalski, Veronica Palazzo-Michalska, Łukasz Pach, Barbara Dziuk, Magdalena Świder & Nikola Zmarzły. (2021) Crosstalk between Statins and Cancer Prevention and Therapy: An Update. Pharmaceuticals 14:12, pages 1220.
Crossref
Malgorzata K. Nowakowska, Xiudong Lei, Mikayla T. Thompson, Simona F. Shaitelman, Mackenzie R. Wehner, Wendy A. Woodward, Sharon H. Giordano & Kevin T. Nead. (2021) Association of statin use with clinical outcomes in patients with triple‐negative breast cancer. Cancer 127:22, pages 4142-4150.
Crossref
Omar Fahmy, Nabil A. Alhakamy, Waleed Y. Rizg, Alaa Bagalagel, Abdulmohsin J. Alamoudi, Hibah M. Aldawsari, Aiah M. Khateb, Basmah M. Eldakhakhny, Usama A. Fahmy, Wesam H. Abdulaal, Claudia G. Fresta & Giuseppe Caruso. (2021) Updates on Molecular and Biochemical Development and Progression of Prostate Cancer. Journal of Clinical Medicine 10:21, pages 5127.
Crossref
Amir R. Afshari, Hamid Mollazadeh, Neil C. Henney, Tannaz Jamialahmad & Amirhossein Sahebkar. (2021) Effects of statins on brain tumors: a review. Seminars in Cancer Biology 73, pages 116-133.
Crossref
Huakan Zhao, Lei Wu, Guifang Yan, Yu Chen, Mingyue Zhou, Yongzhong Wu & Yongsheng Li. (2021) Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduction and Targeted Therapy 6:1.
Crossref
Gi-Hoon Nam, Minsu Kwon, Hanul Jung, Eunbyeol Ko, Seong A Kim, Yoonjeong Choi, Su Jeong Song, Seohyun Kim, Yeji Lee, Gi Beom Kim, Jihoon Han, Jiwan Woo, Yakdol Cho, Cherlhyun Jeong, Seung-Yoon Park, Thomas M. Roberts, Yong Beom Cho & In-San Kim. (2021) Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer. Journal for ImmunoTherapy of Cancer 9:7, pages e002474.
Crossref
Chung-Tsui Huang & Yao-Jen Liang. (2021) Anti-tumor effect of statin on pancreatic adenocarcinoma: From concept to precision medicine. World Journal of Clinical Cases 9:18, pages 4500-4505.
Crossref
Mayu Hosio, Elina Urpilainen, Ari Hautakoski, Mikko Marttila, Martti Arffman, Reijo Sund, Anne Ahtikoski, Ulla Puistola, Esa Läärä, Peeter Karihtala & Arja Jukkola. (2021) Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes. Scientific Reports 11:1.
Crossref
Nils Skajaa, David Nagy, Frederikke Schønfeldt Troelsen, Dóra Körmendiné Farkas & Henrik Toft Sørensen. (2021) Venous thromboembolism and risk of cancer in users of statins: A Danish population-based cohort study. Thrombosis Research 201, pages 1-5.
Crossref
Anna K. Gergen, Patrick D. Kohtz, Alison L. Halpern, Allana M. White, Xianzhong Meng, David A. Fullerton & Michael J. Weyant. (2021) Statins Inhibit Toll-Like Receptor 4–Mediated Growth of Human Esophageal Adenocarcinoma Cells. Journal of Surgical Research 260, pages 436-447.
Crossref
Kritika Prasai, Sri Harsha Tella, Siddhartha Yadav, Anuhya Kommalapati, Kristin Mara, Mohamed Mady, Mohamed A. Hassan, Nicha Wongjarupong, Natalia Rodriguez-Payan, Mitesh Borad, Tushar Patel, Lewis R. Roberts & Amit Mahipal. (2021) Aspirin and Statin Use and the Risk of Gallbladder Cancer. Cancers 13:5, pages 1186.
Crossref
Tae Jin Kwon, Tae Jun Kim, Hyuk Lee, Yang Won Min, Byung-Hoon Min, Jun Haeng Lee & Jae J. Kim. (2021) Statin Use Decreases the Risk of Metachronous Gastric Cancer in Patients without Helicobacter pylori Infection. Cancers 13:5, pages 1020.
Crossref
Tak Kyu Oh & In-Ae Song. (2020) Drug-specific and dosage effects of statins and the risk of cancer: a population-based cohort study in South Korea. European Journal of Cancer Prevention 30:2, pages 188-194.
Crossref
Dongyu Zhang, Yuzhi Xi & Yilin Feng. (2020) Ovarian cancer risk in relation to blood lipid levels and hyperlipidemia: a systematic review and meta-analysis of observational epidemiologic studies. European Journal of Cancer Prevention 30:2, pages 161-170.
Crossref
Ibukunoluwapo O. Zabroski & Matthew A. Nugent. (2021) Lipid Raft Association Stabilizes VEGF Receptor 2 in Endothelial Cells. International Journal of Molecular Sciences 22:2, pages 798.
Crossref
Umesh Goneppanavar & Jasvinder Kaur. 2021. Textbook of Onco-Anesthesiology. Textbook of Onco-Anesthesiology 13 41 .
AJN Raymakers, D. D. Sin, M. Sadatsafavi, JM FitzGerald, C. A. Marra & L. D. Lynd. (2020) Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study. Respiratory Research 21:1.
Crossref
L.A. Schuckmann, K. Khosrotehrani, R. Ghiasvand, M.C.B. Hughes, J.C. Pols, M. Malt, B.M. Smithers & A.C. Green. (2020) Statins may reduce disease recurrence in patients with ulcerated primary melanoma. British Journal of Dermatology 183:6, pages 1049-1055.
Crossref
Young Ran Lee, Sarah Soyeon Oh, Sung-In Jang & Eun-Cheol Park. (2020) Statin adherence and risk of all-cause, cancer, and cardiovascular mortality among dyslipidemia patients: A time-dependent analysis. Nutrition, Metabolism and Cardiovascular Diseases 30:12, pages 2207-2214.
Crossref
Sanaz Dastghaib, Shahla Shojaei, Zohreh Mostafavi-Pour, Pawan Sharma, John B. Patterson, Afshin Samali, Pooneh Mokarram & Saeid Ghavami. (2020) Simvastatin Induces Unfolded Protein Response and Enhances Temozolomide-Induced Cell Death in Glioblastoma Cells. Cells 9:11, pages 2339.
Crossref
Arash Goodarzi, Mehdi Khanmohammadi, Arman Ai, Hamid Khodayari, Armin Ai, Morteza Sagharjoghi Farahani, Saeed Khodayari, Somayeh Ebrahimi-Barough, Sanam Mohandesnezhad & Jafar Ai. (2020) Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model. Molecular Biology Reports 47:10, pages 7783-7795.
Crossref
Kyle J. Gu & Guojun Li. (2020) An Overview of Cancer Prevention: Chemoprevention and Immunoprevention. Journal of Cancer Prevention 25:3, pages 127-135.
Crossref
Srikanth Tangelloju, Bert B. Little, Robert J. Esterhay, Guy Brock & Scott LaJoie. (2020) Statins are associated with new onset type 2 diabetes mellitus (T2DM) in Medicare patients ≥65 years. Diabetes/Metabolism Research and Reviews 36:6.
Crossref
Naeun Lee, Nirmala Tilija Pun, Won‐Jun Jang, Jung Woo Bae & Chul‐Ho Jeong. (2020) Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of FOXO3a. Journal of Cellular and Molecular Medicine 24:12, pages 7055-7066.
Crossref
Etienne Ho Kit Mok & Terence Kin Wah Lee. (2020) The Pivotal Role of the Dysregulation of Cholesterol Homeostasis in Cancer: Implications for Therapeutic Targets. Cancers 12:6, pages 1410.
Crossref
Maryam Zamanian-Daryoush, Daniel J. Lindner, Jennifer Buffa, Banu Gopalan, Jie Na, Stanley L. Hazen & Joseph A. DiDonato. (2020) Apolipoprotein A-I anti-tumor activity targets cancer cell metabolism. Oncotarget 11:19, pages 1777-1796.
Crossref
Jing Yang, Chunyu Li, Ying Shen, Hong Zhou, Yueqin Shao, Wei Zhu & Yan Chen. (2020) Impact of statin use on cancer-specific mortality and recurrence. Medicine 99:14, pages e19596.
Crossref
Woo-Keun Seo, Mersedeh Bahr Hosseini, Oh Young Bang & David S. Liebeskind. (2020) Recent updates in dyslipidemia management: perspectives in stroke-specific situation. Precision and Future Medicine 4:1, pages 9-20.
Crossref
Yu-Ching Chou, Chih-Hung Lin, Chih-Shung Wong, Wan-Yun Chou, Jin-Yin Chang & Chien-An Sun. (2023) Statin use and the Risk of Renal Cell Carcinoma: National Cohort Study. Journal of Investigative Medicine 68:3, pages 776-781.
Crossref
James Yarmolinsky, Caroline J. Bull, Emma E. Vincent, Jamie Robinson, Axel Walther, George Davey Smith, Sarah J. Lewis, Caroline L. Relton & Richard M. Martin. (2020) Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer. JAMA 323:7, pages 646.
Crossref
Hyo-Sun You, Nayoung You, Jae-Woo Lee, Hyoung-Ji Lim, Joungyoun Kim & Hee-Taik Kang. (2020) Inverse Association between Statin Use and Stomach Cancer Incidence in Individuals with Hypercholesterolemia, from the 2002–2015 NHIS-HEALS Data. International Journal of Environmental Research and Public Health 17:3, pages 1054.
Crossref
Gwang Hun Jeong, Keum Hwa Lee, Jong Yeob Kim, Michael Eisenhut, Andreas Kronbichler, Hans J. van der Vliet, Jae Il Shin & Gabriele Gamerith. (2020) Statin and Cancer Mortality and Survival: An Umbrella Systematic Review and Meta-Analysis. Journal of Clinical Medicine 9:2, pages 326.
Crossref
Romina Armando, Diego Mengual G�mez & Daniel Gomez. (2020) New drugs are not enough‑drug repositioning in oncology: An update. International Journal of Oncology.
Crossref
Jahn Andreas, Scherer Bo, Fritz Gerhard & Honnen Sebastian. (2020) Statins Induce a DAF-16/Foxo-dependent Longevity Phenotype via JNK-1 through Mevalonate Depletion in C. elegans. Aging and disease 11:1, pages 60.
Crossref
Bryson W. Katona & Jennifer M. Weiss. (2020) Chemoprevention of Colorectal Cancer. Gastroenterology 158:2, pages 368-388.
Crossref
Michael A. Reid, Sydney M. Sanderson & Jason W. Locasale. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 127 138.e4 .
Ali Fatehi Hassanabad & Susan A. McBride. (2019) Statins as Potential Therapeutics for Lung Cancer. American Journal of Clinical Oncology 42:9, pages 732-736.
Crossref
Barbara N. Harding, Joseph A. Delaney, Renata R. Urban & Noel S. Weiss. (2019) Use of Statin Medications Following Diagnosis in Relation to Survival among Women with Ovarian Cancer. Cancer Epidemiology, Biomarkers & Prevention 28:7, pages 1127-1133.
Crossref
Ali Fatehi Hassanabad. (2019) Can Statins be Protagonists in Our Approach to Cancer Treatment?. American Journal of Clinical Oncology 42:7, pages 547-548.
Crossref
Charleston F. Christie, Diana Fang, Elizabeth G. Hunt, Morgan E. Morris, Amandine Rovini, Kareem A. Heslop, Gyda C. Beeson, Craig C. Beeson & Eduardo N. Maldonado. (2019) Statin‐dependent modulation of mitochondrial metabolism in cancer cells is independent of cholesterol content. The FASEB Journal 33:7, pages 8186-8201.
Crossref
Yawen Jiang & Weiyi Ni. (2019) Economic Evaluation of the 2016 Chinese Guideline and Alternative Risk Thresholds of Initiating Statin Therapy for the Management of Atherosclerotic Cardiovascular Disease. PharmacoEconomics 37:7, pages 943-952.
Crossref
Keshav Kumar Gupta, Shair Ali & Ranjodh Singh Sanghera. (2018) Pharmacological Options in Atherosclerosis: A Review of the Existing Evidence. Cardiology and Therapy 8:1, pages 5-20.
Crossref
Mayu Hosio, Elina Urpilainen, Mikko Marttila, Ari Hautakoski, Martti Arffman, Reijo Sund, Ulla Puistola, Esa Läärä, Arja Jukkola & Peeter Karihtala. (2019) Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes. Breast Cancer Research and Treatment 175:3, pages 741-748.
Crossref
Giuseppe Berton, Rocco Cordiano, Fiorella Cavuto, Francesco Bagato, Heba Talat Mahmoud & Mattia Pasquinucci. (2019) Association between plasma lipid levels during acute coronary syndrome and long-term malignancy risk. The ABC-4* study on heart disease. BMC Cardiovascular Disorders 19:1.
Crossref
Meysam Gachpazan, Hoda Kashani, Majid Khazaei, Seyed Mahdi Hassanian, Majid Rezayi, Fereshteh Asgharzadeh, Majid Ghayour-Mobarhan, Gordon A. Ferns & Amir Avan. (2019) The Impact of Statin Therapy on the Survival of Patients with Gastrointestinal Cancer. Current Drug Targets 20:7, pages 738-747.
Crossref
Andrew D. Spence, John Busby, Carmel M. Hughes, Brian T. Johnston, Helen G. Coleman & Chris R. Cardwell. (2018) Statin use and survival in patients with gastric cancer in two independent population‐based cohorts. Pharmacoepidemiology and Drug Safety 28:4, pages 460-470.
Crossref
Babatunde Akinwunmi, Allison F. Vitonis, Linda Titus, Kathryn L. Terry & Daniel W. Cramer. (2018) Statin therapy and association with ovarian cancer risk in the New England Case Control (NEC) study. International Journal of Cancer 144:5, pages 991-1000.
Crossref
Magdalena Zdybel, Ewa Chodurek & Barbara Pilawa. (2018) Effect of simvastatin in different concentrations on free radicals in A‐2058 human melanoma malignum cells—EPR studies . Journal of Cellular Biochemistry 120:2, pages 2483-2492.
Crossref
Belal A. Al-Husein, Bara’ Dawah, Saleem Bani-Hani, Samir M. Al Bashir, Khaled M. Al-Sawalmeh & Nehad M. Ayoub. (2018) Immunomodulatory effect of statins on Regulatory T Lymphocytes in human colorectal cancer is determined by the stage of disease. Oncotarget 9:87, pages 35752-35761.
Crossref
Anish Vani & James A. Underberg. (2018) Lowering LDL-Cholesterol and CV Benefits: Is There a Limit to How Low LDL-C Needs to be for Optimal Health Benefits?. Clinical Pharmacology & Therapeutics 104:2, pages 290-296.
Crossref
Haige Li, Chen Chen & Dehang Wang. (2018) Low‑frequency ultrasound and microbubbles combined with simvastatin promote the apoptosis of MCF‑7 cells by affecting the LATS1/YAP/RHAMM pathway. Molecular Medicine Reports.
Crossref
Jean Boucher. (2018) Chemoprevention: An Overview of Pharmacologic Agents and Nursing Considerations. Clinical Journal of Oncology Nursing 22:3, pages 350-353.
Crossref
Ye Sel Kim, Moo-Seok Park, Jun-Hwa Lee, Jong-Won Chung, Mi Ji Lee, Chi Kyung Kim, Jin-Man Jung, Kyungmi Oh, Oh Young Bang, Geong-Moon Kim, Ji-Mi Choi, Juneyoung Lee, Chin Sang Chung, Kwang Ho Lee & Woo-Keun Seo. (2018) Effect of Statins on Survival Following Stroke in Patients With Cancer. Frontiers in Neurology 9.
Crossref
Shreyas S. Joshi, Karen Ruth, Marc C. Smaldone, David Y.T. Chen, Richard E. Greenberg, Rosalia Viterbo, Alexander Kutikov & Robert G. Uzzo. (2018) Perioperative Statin Use and Acute Kidney Injury in Patients Undergoing Partial Nephrectomy. Kidney Cancer 2:1, pages 47-55.
Crossref
Pinkal Desai, Robert Wallace, Matthew L. Anderson, Barbara V. Howard, Roberta M. Ray, Chunyuan Wu, Monika Safford, Lisa W. Martin, Thomas Rohan, JoAnn E. Manson & Michael S. Simon. (2018) An analysis of the association between statin use and risk of endometrial and ovarian cancers in the Women's Health Initiative. Gynecologic Oncology 148:3, pages 540-546.
Crossref
Alfredo Caro-Maldonado, Laura Camacho, Amaia Zabala-Letona, Verónica Torrano, Sonia Fernández-Ruiz, Kepa Zamacola-Bascaran, Leire Arreal, Lorea Valcárcel-Jiménez, Natalia Martín-Martín, Juana M. Flores, Ana R. Cortazar, Patricia Zúñiga-García, Amaia Arruabarrena-Aristorena, Fabienne Guillaumond, Diana Cabrera, Juan M. Falcón-Perez, Ana M. Aransay, Antonio Gomez-Muñoz, Mireia Olivan, Juan Morote & Arkaitz Carracedo. (2017) Low-dose statin treatment increases prostate cancer aggressiveness. Oncotarget 9:2, pages 1494-1504.
Crossref
Bum Sung Kim, Jeong Hoon Yang, Woo Jin Jang, Young Bin Song, Joo-Yong Hahn, Jin-Ho Choi, Ki Hong Choi, Sung-Hea Kim, Woo Jung Chun, Hyeon-Cheol Gwon & Seung-Hyuk Choi. (2018) Long-term Survival Benefit of Statin in Patients with Coronary Chronic Total Occlusion without Revascularization. Journal of Korean Medical Science 33:18.
Crossref
Geoffrey C. Kabat, Mimi Y. Kim, Rowan T. Chlebowski, Mara Z. Vitolins, Sylvia Wassertheil-Smoller & Thomas E. Rohan. (2017) Serum lipids and risk of obesity-related cancers in postmenopausal women. Cancer Causes & Control 29:1, pages 13-24.
Crossref
Ashutosh K. Tewari, Jennifer A. Stockert, Shalini S. Yadav, Kamlesh K. Yadav & Irtaza Khan. 2018. Cell & Molecular Biology of Prostate Cancer. Cell & Molecular Biology of Prostate Cancer 41 65 .
Md. Mohaimenul Islam, Hsuan-Chia Yang, Phung-Anh Nguyen, Tahmina Nasrin Poly, Chih-Wei Huang, Shwetambara Kekade, Abdulwahed Mohammed Khalfan, Tonmoy Debnath, Yu-Chuan Jack Li & Shabbir Syed Abdul. (2017) Exploring association between statin use and breast cancer risk: an updated meta-analysis. Archives of Gynecology and Obstetrics 296:6, pages 1043-1053.
Crossref
Signe Benzon LarsenChristian DehlendorffCharlotte SkriverSusanne Oksbjerg DaltonChristina Gade JespersenMichael BorreKlaus BrassoMette NørgaardChristoffer JohansenHenrik Toft SørensenJesper HallasSøren Friis. (2017) Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer. Journal of Clinical Oncology 35:29, pages 3290-3297.
Crossref
Linda Sleire, Hilde Elise Førde, Inger Anne Netland, Lina Leiss, Bente Sandvei Skeie & Per Øyvind Enger. (2017) Drug repurposing in cancer. Pharmacological Research 124, pages 74-91.
Crossref
Timothy L. Lash, Anders H. Riis, Eva B. Ostenfeld, Rune Erichsen, Mogens Vyberg, Thomas P. Ahern & Ole Thorlacius-Ussing. (2017) Associations of Statin Use With Colorectal Cancer Recurrence and Mortality in a Danish Cohort. American Journal of Epidemiology 186:6, pages 679-687.
Crossref
Jing Yang, Qiaoling Zhu, Qiao Liu, Yingxia Wang, Weimin Xie & Lili Hu. (2017) Statin use and endometrial cancer risk: a meta-analysis. Oncotarget 8:37, pages 62425-62434.
Crossref
Reetta Arima, Mikko Marttila, Ari Hautakoski, Martti Arffman, Reijo Sund, Pirjo Ilanne-Parikka, Jenni Kangaskokko, Esa Läärä, Ulla Puistola & Marianne Hinkula. (2017) Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes. Gynecologic Oncology 146:3, pages 636-641.
Crossref
Massimo Volpe, Allegra Battistoni, Giovanna Gallo, Roberta Coluccia & Raffaele De Caterina. (2017) Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk. High Blood Pressure & Cardiovascular Prevention 24:3, pages 331-339.
Crossref
Freija Verdoodt, Merete Kjær Hansen, Susanne K. Kjaer, Anton Pottegård, Søren Friis & Christian Dehlendorff. (2017) Statin use and mortality among ovarian cancer patients: A population‐based cohort study. International Journal of Cancer 141:2, pages 279-286.
Crossref
Gagan Chhabra, Mary Ann Ndiaye, Liz Mariely Garcia-Peterson & Nihal Ahmad. (2017) Melanoma Chemoprevention: Current Status and Future Prospects. Photochemistry and Photobiology 93:4, pages 975-989.
Crossref
Heidi S. Wirtz, Gregory S. Calip, Diana S. M. Buist, Julie R. Gralow, William E. Barlow, Shelly Gray & Denise M. Boudreau. (2017) Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors. American Journal of Epidemiology 185:8, pages 661-672.
Crossref
Gad Rennert, Mila Pinchev, Naomi Gronich, Walid Saliba, Anath Flugelman, Idit Lavi, Hadassah Goldberg, Georgeta Fried, Mariana Steiner, Arie Bitterman, Keren Landsman & Hedy S. Rennert. (2017) Oral Bisphosphonates and Improved Survival of Breast Cancer. Clinical Cancer Research 23:7, pages 1684-1689.
Crossref
Javier Rivero, Luis Alberto Henríquez-Hernández, Luis D. Boada, Jose Pestano, Octavio P. Luzardo, María Camacho, Manuel Zumbado & Pilar F. Valerón. (2017) Simvastatin down-regulates differential genetic profiles produced by organochlorine mixtures in primary breast cell (HMEC). Chemico-Biological Interactions 268, pages 85-92.
Crossref
Hiroshi Yokomichi, Akiko Nagai, Makoto Hirata, Akiko Tamakoshi, Yutaka Kiyohara, Yoichiro Kamatani, Kaori Muto, Toshiharu Ninomiya, Koichi Matsuda, Michiaki Kubo, Yusuke Nakamura, Zentaro Yamagata, Kazuo Misumi, Nobuyoshi Higa, Sunao Matsubayashi, Kei Matsuura, Shiro Minami, Hitoshi Sugihara, Naoya Emoto, Hirotoshi Ohmura, Akihiro Inui, Michihiro Ogasawara, Satoshi Asai, Mitsu- hiko Moriyama, Yasuo Takahashi, Tomoaki Fujioka, Wataru Obara, Seijiro Mori, Hideki Ito, Satoshi Nagayama, Yoshio Miki, Akihide Masumoto, Akira Yamada, Yasuko Nishizawa, Ken Kodama, Satoshi Ugi, Hiroshi Maegawa, Yukihiro Koretsune, Hideo Kusuoka & Masako Ueyama. (2017) Statin use and all-cause and cancer mortality: BioBank Japan cohort. Journal of Epidemiology 27:3, pages S84-S91.
Crossref
Guillaume Sarrabayrouse, Christine Pich, Iotefa Teiti & Anne Françoise Tilkin-Mariame. (2017) Regulatory properties of statins and rho gtpases prenylation inhibitiors to stimulate melanoma immunogenicity and promote anti-melanoma immune response. International Journal of Cancer 140:4, pages 747-755.
Crossref
Ange Wang, Aaron K Aragaki, Jean Y Tang, Allison W Kurian, JoAnn E Manson, Rowan T Chlebowski, Michael Simon, Pinkal Desai, Sylvia Wassertheil-Smoller, Simin Liu, Stephen Kritchevsky, Heather A Wakelee & Marcia L Stefanick. (2016) Reply to Comment on ‘Statin use and all-cancer survival: prospective results from the Women’s Health Initiative’. British Journal of Cancer 116:3, pages e2-e2.
Crossref
Juana Virginia Tapia-Vieyra, Blanca Delgado-Coello & Jaime Mas-Oliva. (2017) Atherosclerosis and Cancer; A Resemblance with Far-reaching Implications. Archives of Medical Research 48:1, pages 12-26.
Crossref
Soheil Tavakolpour, Maryam Daneshpazhooh & HamidReza Mahmoudi. 2017. Cancer Genetics and Psychotherapy. Cancer Genetics and Psychotherapy 851 934 .
Ange Wang, Heather A. Wakelee, Aaron K. Aragaki, Jean Y. Tang, Allison W. Kurian, JoAnn E. Manson & Marcia L. Stefanick. (2016) Protective Effects of Statins in Cancer: Should They Be Prescribed for High-Risk Patients?. Current Atherosclerosis Reports 18:12.
Crossref
Takaaki Higashi, Hiromitsu Hayashi, Yuki Kitano, Kensuke Yamamura, Takayoshi Kaida, Kota Arima, Katsunobu Taki, Shigeki Nakagawa, Hirohisa Okabe, Hidetoshi Nitta, Katsunori Imai, Daisuke Hashimoto, Akira Chikamoto, Toru Beppu & Hideo Baba. (2016) Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma. Medical Oncology 33:11.
Crossref
Alexei Vazquez, Jurre J. Kamphorst, Elke K. Markert, Zachary T. Schug, Saverio Tardito & Eyal Gottlieb. (2016) Cancer metabolism at a glance. Journal of Cell Science 129:18, pages 3367-3373.
Crossref
Ange Wang, Jean Y Tang & Marcia L Stefanick. (2016) Relation of statin use with non-melanoma skin cancer: Prospective results from the Women’s Health Initiative. Women's Health 12:5, pages 453-455.
Crossref
Johan Frostegård, Yong Zhang, Jitong Sun, Keqiang Yan & Anquan Liu. (2016) Oxidized Low‐Density Lipoprotein (OxLDL)–Treated Dendritic Cells Promote Activation of T Cells in Human Atherosclerotic Plaque and Blood, Which Is Repressed by Statins: microRNA let‐7c Is Integral to the Effect. Journal of the American Heart Association 5:9.
Crossref
S. Bhavsar, K. Hagan, R. Arunkumar, Y. Potylchansky, R. Grasu, A. Dang, R. Carlson, C. Cowels, B. Arnold, T.F. Rahlfs, I. Lipski, C. Walsh, A.T. Nguyen, L. Feng & J.P. Cata. (2016) Preoperative statin use is not associated with improvement in survival after glioblastoma surgery. Journal of Clinical Neuroscience 31, pages 176-180.
Crossref
Tatiana Y. Hargrove, Laura Friggeri, Zdzislaw Wawrzak, Suneethi Sivakumaran, Eugenia M. Yazlovitskaya, Scott W. Hiebert, F. Peter Guengerich, Michael R. Waterman & Galina I. Lepesheva. (2016) Human sterol 14α-demethylase as a target for anticancer chemotherapy: towards structure-aided drug design. Journal of Lipid Research 57:8, pages 1552-1563.
Crossref
Ange Wang, Aaron K Aragaki, Jean Y Tang, Allison W Kurian, JoAnn E Manson, Rowan T Chlebowski, Michael Simon, Pinkal Desai, Sylvia Wassertheil-Smoller, Simin Liu, Stephen Kritchevsky, Heather A Wakelee & Marcia L Stefanick. (2016) Statin use and all-cancer survival: prospective results from the Women’s Health Initiative. British Journal of Cancer 115:1, pages 129-135.
Crossref
Anton Pottegård, Peter Clark, Søren Friis, Jesper Hallas & Lars Lund. (2016) Long-term Use of Statins and Risk of Renal Cell Carcinoma: A Population-based Case–Control Study. European Urology 69:5, pages 877-882.
Crossref
Emma H. Allott, Laura Farnan, Susan E. Steck, Lenore Arab, L. Joseph Su, Merle Mishel, Elizabeth T.H. Fontham, James L. Mohler & Jeannette T. Bensen. (2016) Statin Use and Prostate Cancer Aggressiveness: Results from the Population-Based North Carolina–Louisiana Prostate Cancer Project. Cancer Epidemiology, Biomarkers & Prevention 25:4, pages 670-677.
Crossref
Bernadette McGuinness, David Craig, Roger Bullock & Peter Passmore. (2016) Statins for the prevention of dementia. Cochrane Database of Systematic Reviews 2016:1.
Crossref
Shelley S. Tworoger & Tianyi Huang. 2016. Obesity and Cancer. Obesity and Cancer 155 176 .
Ahmed Q. Haddad, Lai Jiang, Jeffrey A. Cadeddu, Yair Lotan, Jeffrey C. Gahan, Linda S. Hynan, Neil Gupta, Ganesh V. Raj, Arthur I. Sagalowsky & Vitaly Margulis. (2015) Statin Use and Serum Lipid Levels Are Associated With Survival Outcomes After Surgery for Renal Cell Carcinoma. Urology 86:6, pages 1146-1152.
Crossref
Søren Friis, Ausrele Kesminiene, Carolina Espina, Anssi Auvinen, Kurt Straif & Joachim Schüz. (2015) European Code against Cancer 4th Edition: Medical exposures, including hormone therapy, and cancer. Cancer Epidemiology 39, pages S107-S119.
Crossref
Alison M. Mondul, Steven C. Moore, Stephanie J. Weinstein, Edward D. Karoly, Joshua N. Sampson & Demetrius Albanes. (2015) Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha‐tocopherol, beta‐carotene cancer prevention (ATBC) study. International Journal of Cancer 137:9, pages 2124-2132.
Crossref
Ishak Mansi & Biff F. Palmer. (2015) Statin Adverse Events in Primary Prevention: Between Randomized Trials and Observational Studies. The American Journal of the Medical Sciences 350:4, pages 330-337.
Crossref
Shanthini M. Crusz & Frances R. Balkwill. (2015) Inflammation and cancer: advances and new agents. Nature Reviews Clinical Oncology 12:10, pages 584-596.
Crossref
Elizabeth D. Kantor, Loren Lipworth, Jay H. Fowke, Edward L. Giovannucci, Lorelei A. Mucci & Lisa B. Signorello. (2015) Statin use and risk of prostate cancer: Results from the Southern Community Cohort Study. The Prostate 75:13, pages 1384-1393.
Crossref
Chun-Jung Lin, Cheng-Kuo Lai, Min-Chuan Kao, Lii-Tzu Wu, U-Ging Lo, Li-Chiung Lin, Yu-An Chen, Ho Lin, Jer-Tsong Hsieh, Chih-Ho Lai & Chia-Der Lin. (2015) Impact of cholesterol on disease progression. BioMedicine 5:2.
Crossref
Ying Ling, Li Yang, Huiqiao Huang, Xiaohua Hu, Cuisong Zhao, Hongyan Huang & Yanping Ying. (2015) Prognostic Significance of Statin Use in Colorectal Cancer. Medicine 94:25, pages e908.
Crossref
Allegra Battistoni, Vittoria Mastromarino & Massimo Volpe. (2015) Reducing Cardiovascular and Cancer Risk: How to Address Global Primary Prevention in Clinical Practice. Clinical Cardiology 38:6, pages 387-394.
Crossref
CRISTIAN G TORRES, ARACELI OLIVARES & CAROLL STOORE. (2015) Simvastatin exhibits antiproliferative effects on spheres derived from canine mammary carcinoma cells. Oncology Reports 33:5, pages 2235-2244.
Crossref
Chris R. Cardwell, Úna Mc Menamin, Carmel M. Hughes & Liam J. Murray. (2015) Statin Use and Survival from Lung Cancer: A Population-Based Cohort Study. Cancer Epidemiology, Biomarkers & Prevention 24:5, pages 833-841.
Crossref
T.-Y. Yang, W.-M. Lin, C.-L. Lin, F.-C. Sung & C.-H. Kao. (2015) Correlation between use of simvastatin and lovastatin and female lung cancer risk: a nationwide case-control study. International Journal of Clinical Practice 69:5, pages 571-576.
Crossref
Liv Mundal, Mirza Sarancic, Leiv Ose, Per Ole Iversen, Jens-Kristian Borgan, Marit B. Veierød, Trond P. Leren & Kjetil Retterstøl. (2015) Økt dødelighet med familiær hyperkolesterolemi. Tidsskrift for Den norske legeforening 135:11, pages 1024-1025.
Crossref
L Baandrup, C Dehlendorff, S Friis, J H Olsen & S K Kjær. (2014) Statin use and risk for ovarian cancer: a Danish nationwide case–control study. British Journal of Cancer 112:1, pages 157-161.
Crossref
Liv Mundal, Mirza Sarancic, Leiv Ose, Per Ole Iversen, Jens‐Kristian Borgan, Marit B. Veierød, Trond P. Leren & Kjetil Retterstøl. (2014) Mortality Among Patients With Familial Hypercholesterolemia: A Registry‐Based Study in Norway, 1992–2010. Journal of the American Heart Association 3:6.
Crossref
Gonzalo López-Abente, Nuria Aragonés, Beatriz Pérez-Gómez, Marina Pollán, Javier García-Pérez, Rebeca Ramis & Pablo Fernández-Navarro. (2014) Time trends in municipal distribution patterns of cancer mortality in Spain. BMC Cancer 14:1.
Crossref
Peter Orendáš, Peter Kubatka, Bianka Bojková, Monika Kassayová, Karol Kajo, Desanka Výbohová, Peter Kružliak, Martin Péč, Marián Adamkov, Andrea Kapinová, Katarína Adamicová, Vladimíra Sadloňová, Martina Chmelová & Nadežda Stollárová. (2014) Melatonin potentiates the anti-tumour effect of pravastatin in rat mammary gland carcinoma model. International Journal of Experimental Pathology 95:6, pages 401-410.
Crossref
Yaa-Hui Dong, Jou-Wei Lin, Li-Chiu Wu, Chung-Yu Chen, Chia-Hsuin Chang, Kuan-Yu Chen & Mei-Shu Lai. (2014) Examining the association between statins and lung cancer incidence in patients with type 2 diabetes mellitus. Journal of the Formosan Medical Association 113:12, pages 940-948.
Crossref
Chris R. CardwellBlanaid M. HicksCarmel HughesLiam J. Murray. (2014) Statin Use After Colorectal Cancer Diagnosis and Survival: A Population-Based Cohort Study. Journal of Clinical Oncology 32:28, pages 3177-3183.
Crossref
P Jiang, R Mukthavaram, Y Chao, N Nomura, I S Bharati, V Fogal, S Pastorino, D Teng, X Cong, S C Pingle, S Kapoor, K Shetty, A Aggrawal, S Vali, T Abbasi, S Chien & S Kesari. (2014) In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells. British Journal of Cancer 111:8, pages 1562-1571.
Crossref
Natália António, Ana Soares, Rosa Fernandes, Francisco Soares, Ana Lopes, Tiago Carvalheiro, Artur Paiva, Luís A. Providência, Lino Gonçalves & Carlos Fontes Ribeiro. (2014) Endothelial progenitor cells in diabetic patients with myocardial infarction – Can statins improve their function?. European Journal of Pharmacology 741, pages 25-36.
Crossref
Stefanos Bonovas. (2014) Statins: Do They Have a Potential Role in Cancer Prevention and Modifying Cancer-Related Outcomes?. Drugs 74:16, pages 1841-1848.
Crossref
Elisabeth Livingstone, Loes M. Hollestein, Myrthe P. P. Herk‐Sukel, Lonneke Poll‐Franse, Arjen Joosse, Bastian Schilling, Tamar Nijsten, Dirk Schadendorf & Esther Vries. (2014) Statin use and its effect on all‐cause mortality of melanoma patients: a population‐based Dutch cohort study. Cancer Medicine 3:5, pages 1284-1293.
Crossref
M. Shi, H. Zheng, B. Nie, W. Gong & X. Cui. (2014) Statin use and risk of liver cancer: an update meta-analysis. BMJ Open 4:9, pages e005399-e005399.
Crossref
Elizabeth A. Platz, Catherine M. Tangen, Phyllis J. Goodman, Cathee Till, Howard L. Parnes, William D. Figg, Demetrius Albanes, Marian L. Neuhouser, Eric A. Klein, M. Scott Lucia, Ian M. ThompsonJr.Jr. & Alan R. Kristal. (2014) Statin Drug Use is Not Associated with Prostate Cancer Risk in Men Who are Regularly Screened. The Journal of Urology 192:2, pages 379-384.
Crossref
Yanqiong Liu, Aiping Qin, Taijie Li, Xue Qin & Shan Li. (2014) Effect of statin on risk of gynecologic cancers: A meta-analysis of observational studies and randomized controlled trials. Gynecologic Oncology 133:3, pages 647-655.
Crossref
Vinay Prasad & Nancy Ho. (2014) Why do we continue to adopt medical practices based on pathophysiology alone when we should be insisting on clinical trials?. Journal of Clinical Epidemiology 67:4, pages 361-363.
Crossref
Denise M. Boudreau, Onchee Yu, Jessica Chubak, Heidi S. Wirtz, Erin J. Aiello Bowles, Monica Fujii & Diana S. M. Buist. (2014) Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer. Breast Cancer Research and Treatment 144:2, pages 405-416.
Crossref
Christina G. Jespersen, Mette Nørgaard, Søren Friis, Charlotte Skriver & Michael Borre. (2014) Statin use and risk of prostate cancer: A Danish population-based case-control study, 1997–2010. Cancer Epidemiology 38:1, pages 42-47.
Crossref
Wakana Ohashi & Yuichi Hattori. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 675 682 .
Michael J. Gonyeau. (2013) The Spectrum of Statin Therapy in Cancer Patients: Is There a Need for Further Investigation?. Current Atherosclerosis Reports 16:1.
Crossref
Elena N. Atochina-Vasserman, Dmitry A. Goncharov, Alla V. Volgina, Megan Milavec, Melane L. James & Vera P. Krymskaya. (2013) Statins in Lymphangioleiomyomatosis. Simvastatin and Atorvastatin Induce Differential Effects on tuberous sclerosis complex 2 –Null Cell Growth and Signaling . American Journal of Respiratory Cell and Molecular Biology 49:5, pages 704-709.
Crossref
Jing Liu, Aimin Xu, Karen Siu-Ling Lam, Nai-Sum Wong, Jie Chen, Peter R Shepherd & Yu Wang. (2013) Cholesterol-induced mammary tumorigenesis is enhanced by adiponectin deficiency: role of LDL receptor upregulation. Oncotarget 4:10, pages 1804-1818.
Crossref
Laurent Corcos & Catherine Le Jossic-Corcos. (2013) Statins: Perspectives in cancer therapeutics. Digestive and Liver Disease 45:10, pages 795-802.
Crossref
Jie Liao, Yeon T. Chung, Allison L. Yang, Meng Zhang, Haonan Li, Wanying Zhang, Liang Yan & Guang‐Yu Yang. (2012) Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL‐Kras G12D ‐LSL‐Trp53 R172H ‐Pdx1‐Cre mice . Molecular Carcinogenesis 52:9, pages 739-750.
Crossref
Peter Kubatka, Nadežda Stollárová, Jozef Škarda, Katarína Žihlavníková, Karol Kajo, Andrea Kapinová, Katarína Adamicová, Martin Péč, Dušan Dobrota, Bianka Bojková, Monika Kassayová & Peter Orendáš. (2013) Preventive effects of fluvastatin in rat mammary carcinogenesis. European Journal of Cancer Prevention 22:4, pages 352-357.
Crossref
Chun Chao, Stephen G. Williams, Lanfang Xu, Jergin Chen, Lauren P. Wallner, Kimberly R. Porter & Steven J. Jacobsen. (2013) Statin therapy is not associated with prostate cancer recurrence among patients who underwent radiation therapy. Cancer Letters 335:1, pages 214-218.
Crossref
Shih-Wei Lai, Kuan-Fu Liao, Hsueh-Chou Lai, Chih-Hsin Muo, Fung-Chang Sung & Pei-Chun Chen. (2013) Statin use and risk of hepatocellular carcinoma. European Journal of Epidemiology 28:6, pages 485-492.
Crossref
Michael Kirby. (2013) Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy. BJU International 111:6, pages 854-856.
Crossref
Chun Chao, Steven J. Jacobsen, Lanfang Xu, Lauren P. Wallner, Kimberly R. Porter & Stephen G. Williams. (2013) Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy. BJU International 111:6, pages 954-962.
Crossref
Danitza Pradelli, Davide Soranna, Lorenza Scotti, Antonella Zambon, Alberico Catapano, Giuseppe Mancia, Carlo La Vecchia & Giovanni Corrao. (2013) Statins and primary liver cancer. European Journal of Cancer Prevention 22:3, pages 229-234.
Crossref
Zoe Clancy, Scott W. Keith, Carol Rabinowitz, Matteo Ceccarelli, Joshua J. Gagne & Vittorio Maio. (2013) Statins and colorectal cancer risk: a longitudinal study. Cancer Causes & Control 24:4, pages 777-782.
Crossref
Thomas Broughton, Jamie Sington & Ian L. P. Beales. (2012) Statin use is associated with a reduced incidence of colorectal adenomatous polyps. International Journal of Colorectal Disease 28:4, pages 469-476.
Crossref
Øystein Kravdal. (2013) The poorer cancer survival among the unmarried in Norway: Is much explained by comorbidities?. Social Science & Medicine 81, pages 42-52.
Crossref
D Gaist, L Andersen, J Hallas, H Toft Sørensen, H D Schrøder & S Friis. (2013) Use of statins and risk of glioma: a nationwide case–control study in Denmark. British Journal of Cancer 108:3, pages 715-720.
Crossref
Archana Gopalan, Weiping Yu, Bob G. Sanders & Kimberly Kline. (2013) Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway. Cancer Letters 329:1, pages 9-16.
Crossref
Virginia Kaklamani. 2013. Management of the Patient at High Risk for Breast Cancer. Management of the Patient at High Risk for Breast Cancer 97 101 .
Thomas Broughton, Jamie Sington & Ian LP Beales. (2012) Statin use is associated with a reduced incidence of colorectal cancer: a colonoscopy-controlled case–control study. BMC Gastroenterology 12:1.
Crossref
J W Clendening & L Z Penn. (2012) Targeting tumor cell metabolism with statins. Oncogene 31:48, pages 4967-4978.
Crossref
Sune F. Nielsen, Børge G. Nordestgaard & Stig E. Bojesen. (2012) Statin Use and Reduced Cancer-Related Mortality. New England Journal of Medicine 367:19, pages 1792-1802.
Crossref
D. R. Tasat & J. S. Yakisich. (2012) Expanding the pleiotropic effects of statins: attenuation of air pollution-induced inflammatory response. American Journal of Physiology-Lung Cellular and Molecular Physiology 303:8, pages L640-L641.
Crossref
M Cuperlovic-CulfAS Culf, M Touaibia & N Lefort. (2012) Targeting the latest hallmark of cancer: another attempt at ‘magic bullet’ drugs targeting cancers’ metabolic phenotype. Future Oncology 8:10, pages 1315-1330.
Crossref
June M. Chan, Stephanie Litwack-Harrison, Scott R. Bauer, Nicholas A. Daniels, Timothy J. Wilt, Jackilen Shannon & Douglas C. Bauer. (2012) Statin Use and Risk of Prostate Cancer in the Prospective Osteoporotic Fractures in Men (MrOS) Study. Cancer Epidemiology, Biomarkers & Prevention 21:10, pages 1886-1888.
Crossref
L. Alexandre, A. B. Clark, E. Cheong, M. P. N. Lewis & A. R. Hart. (2012) Systematic review: potential preventive effects of statins against oesophageal adenocarcinoma. Alimentary Pharmacology & Therapeutics 36:4, pages 301-311.
Crossref
Eric J. Jacobs, Victoria L. Stevens, Christina C. Newton & Susan M. Gapstur. (2012) Plasma total, LDL, and HDL cholesterol and risk of aggressive prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Causes & Control 23:8, pages 1289-1296.
Crossref
Lidia Daimiel, Teodoro Vargas & Ana Ramírez de Molina. (2012) Nutritional genomics for the characterization of the effect of bioactive molecules in lipid metabolism and related pathways. ELECTROPHORESIS 33:15, pages 2266-2289.
Crossref
Xiaobing Cui, Yue Xie, Min Chen, Jun Li, Xiaoming Liao, Jian Shen, Meng Shi, Wenjing Li, Haoxuan Zheng & Bo Jiang. (2012) Statin use and risk of pancreatic cancer: a meta-analysis. Cancer Causes & Control 23:7, pages 1099-1111.
Crossref
Janel Suburu & Yong Q. Chen. (2012) Lipids and prostate cancer. Prostaglandins & Other Lipid Mediators 98:1-2, pages 1-10.
Crossref
Nathan Vandjelovic, Hong Zhu, Hara P. Misra, Ryan P. Zimmerman, Zhenquan Jia & Yunbo Li. (2011) EPR studies on hydroxyl radical-scavenging activities of pravastatin and fluvastatin. Molecular and Cellular Biochemistry 364:1-2, pages 71-77.
Crossref
Peter BrodersenLali Sakvarelidze-AchardHubert SchallerMehdi Khafif, Grégory Schott, Abdelhafid Bendahmane & Olivier Voinnet. (2012) Isoprenoid biosynthesis is required for miRNA function and affects membrane association of ARGONAUTE 1 in Arabidopsis . Proceedings of the National Academy of Sciences 109:5, pages 1778-1783.
Crossref
G. Rennert. (2011) Bisphosphonates: Beyond Prevention of Bone Metastases. JNCI Journal of the National Cancer Institute 103:23, pages 1728-1729.
Crossref
Yana Vinogradova, Carol Coupland & Julia Hippisley-Cox. (2011) Exposure to statins and risk of common cancers: a series of nested case-control studies. BMC Cancer 11:1.
Crossref
Wen-Bin Zhong, Sung-Po Hsu, Pei-Yin Ho, Yu-Chih Liang, Tien-Chun Chang & Wen-Sen Lee. (2011) Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway. Biochemical Pharmacology 82:11, pages 1663-1672.
Crossref
Peter Kubatka, Katarína Žihlavniková, Peter Solár, Karol Kajo, Vanda Valentová, Martin Péč, Bianka Bojková, Monika Kassayová, Nadežda Stollárová & Ivan Ahlers. (2011) Antitumor effects of atorvastatin in the chemoprevention of rat mammary carcinogenesis. Biologia 66:4, pages 727-734.
Crossref
Li Jiao, Philip R. Taylor, Stephanie J. Weinstein, Barry I. Graubard, Jarmo Virtamo, Demetrius Albanes & Rachael Z. Stolzenberg-Solomon. (2011) Advanced Glycation End Products, Soluble Receptor for Advanced Glycation End Products, and Risk of Colorectal Cancer. Cancer Epidemiology, Biomarkers & Prevention 20:7, pages 1430-1438.
Crossref
Jeremy Bellien, Robinson Joannides, Vincent Richard & Christian Thuillez. (2011) Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: A promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?. Pharmacology & Therapeutics 131:1, pages 1-17.
Crossref
Camil Castelo-Branco. (2011) Statins and cancer: Harmful or helpful?. Maturitas 68:2, pages 198.
Crossref
Maria Coimbra, Manuela Banciu, Marcel H.A.M. Fens, Lieselotte de Smet, Magda Cabaj, Josbert M. Metselaar, Gert Storm & Raymond M. Schiffelers. (2010) Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation. Journal of Controlled Release 148:3, pages 303-310.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.